These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3513518)

  • 21. SD-3211, a novel benzothiazine calcium antagonist, alone and in combination with a beta-adrenoceptor antagonist, produces antihypertensive effects without affecting heart rate and atrioventricular conduction in conscious renal hypertensive dogs.
    Kageyama M; Nishimura K; Takada T; Miyawaki N; Yamauchi H
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):102-7. PubMed ID: 1708042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina.
    Sadick NN; Tan AT; Fletcher PJ; Morris J; Kelly DT
    Circulation; 1982 Sep; 66(3):574-9. PubMed ID: 7046990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive antianginal effect of verapamil in patients receiving propranolol.
    Bassan M; Weiler-Ravell D; Shalev O
    Br Med J (Clin Res Ed); 1982 Apr; 284(6322):1067-70. PubMed ID: 6802408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness.
    Hess OM; Grimm J; Krayenbuehl HP
    Eur Heart J; 1983 Nov; 4 Suppl F():47-56. PubMed ID: 6686544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined therapy with verapamil and propranolol in chronic stable angina.
    Subramanian B; Bowles MJ; Davies AB; Raftery EB
    Am J Cardiol; 1982 Jan; 49(1):125-32. PubMed ID: 7053600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the non-steroidal anti-inflammatory drugs, piroxicam or sulindac, on the antihypertensive actions of propranolol and verapamil.
    Baez MA; Alvarez CR; Weidler DJ
    J Hypertens Suppl; 1987 Dec; 5(5):S563-6. PubMed ID: 3481821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
    Silber S; Vogler A; Theisen K
    Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension.
    Zusman RM; Christensen DM; Federman EB; Ruddy TD; Miller DD; Boucher CA
    Am J Cardiol; 1989 Sep; 64(11):51F-61F. PubMed ID: 2782271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study.
    Winniford MD; Fulton KL; Corbett JR; Croft CH; Hillis LD
    Am J Cardiol; 1985 Feb; 55(4):281-5. PubMed ID: 3969862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined verapamil and propranolol for supraventricular tachycardia.
    Yee R; Gulamhusein SS; Klein GJ
    Am J Cardiol; 1984 Mar; 53(6):757-63. PubMed ID: 6702624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twice-daily verapamil for hypertension: a comparison with propranolol.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am J Cardiol; 1986 Feb; 57(7):93D-98D. PubMed ID: 3513519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravenous verapamil administration on left ventricular diastolic function in systemic hypertension.
    Betocchi S; Cuocolo A; Pace L; Chiariello M; Trimarco B; Alfano B; Ricciardelli B; Salvatore M; Condorelli M
    Am J Cardiol; 1987 Mar; 59(6):624-9. PubMed ID: 3825903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of essential hypertension with PN 200-110 (isradipine).
    Hamilton BP
    Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the antihypertensive effect of verapamil and atenolol.
    Escudero J; Hernandez H; Martinez F
    Am J Cardiol; 1986 Feb; 57(7):54D-58D. PubMed ID: 3513515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil and bendrofluazide in the treatment of hypertension: a controlled study of effectiveness alone and in combination.
    Benjamin N; Phillips RJ; Robinson BF
    Eur J Clin Pharmacol; 1988; 34(3):249-53. PubMed ID: 3294021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit.
    Parodi O; Simonetti I; Michelassi C; Carpeggiani C; Biagini A; L'Abbate A; Maseri A
    Am J Cardiol; 1986 Apr; 57(11):899-906. PubMed ID: 3083668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
    Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
    Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.